OPS
TTOO

Orion Portfolio Solutions’s T2 Biosystems, Inc TTOO Stock Holding History

Orion Portfolio Solutions’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-126
Closed -$2.79K – 1772
2023
Q3 		$2.79K Buy
+126
New +$3.29K ﹤0.01% 1608

Other funds holding TTOO

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Orion Portfolio Solutions's TTOO Position: Q4 2023 in Review

Orion Portfolio Solutions sold out of T2 Biosystems, Inc (TTOO) in Q4 2023, closing a stake of 126 shares — an estimated $2.79K sold.

Orion Portfolio Solutions first reported a position in TTOO in Q3 2023 and held it in 1 quarter. The position peaked at $2.79K in Q3 2023. 21 funds tracked by Wall St. Rank hold TTOO as of Q4 2023.

  • Orion Portfolio Solutions reported no remaining T2 Biosystems, Inc position as of Q4 2023 after selling out during the quarter.
  • Orion Portfolio Solutions sold 126 T2 Biosystems, Inc shares in Q4 2023, an estimated $2.79K.
  • Orion Portfolio Solutions first reported a position in T2 Biosystems, Inc in Q3 2023 and held it in 1 quarter.
  • Orion Portfolio Solutions's T2 Biosystems, Inc position peaked at $2.79K in Q3 2023.
  • 21 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2023.

Based on Orion Portfolio Solutions's 13F filing for Q4 2023, filed 9 Feb 2024.